<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=601572900419438&amp;ev=PageView&amp;noscript=1">

FACILITIES

cGMP Facilities in Vilnius

Northway Biotech's European facilities for protein-based biologics and gene therapies are located in Vilnius, the capital of Lithuania and a center for biotechnological innovation.

Flexible, Modern Facilities

Northway Biotech operates two state-of-the-art facilities in Vilnius, Lithuania, designed to support the development and manufacturing of protein-based biologics and gene therapies.

Our biologics facility includes more than 40 advanced R&D laboratories for cell line development, upstream/downstream process development, and analytical services, alongside cGMP manufacturing suites equipped with both single-use and stainless steel systems. This site supports microbial and mammalian expression platforms and offers full drug substance production as well as aseptic fill-finish capabilities.

In 2024, we expanded our footprint with the opening of the Baltics’ first dedicated gene therapy manufacturing center - an 8,000 m² facility purpose-built for cGMP production of viral vectors and plasmid DNA. This site delivers end-to-end gene therapy CDMO services, including vector production, cell banking, and viral clearance studies.

Together, these two facilities form a robust, flexible, and scalable infrastructure for clients seeking high-quality, integrated biologics and gene therapy manufacturing solutions in the heart of Europe.

R&D SERVICES

Process Development

Our R&D experts work with you to develop processes that can be efficiently transferred and seamlessly scaled up for production.

Learn More

cGMP MANUFACTURING

Drug Substance

With industry-leading expertise and state-of-the-art single-use equipment, we can take your drug substance from concept to commercialization, all within our modern facilities

Learn More